WORLDSymposium opens 2027 abstracts, registration and hotel bookings

WORLDSymposium has opened abstract submissions, award nominations, registration and hotel reservations for its 23rd annual meeting, set for Jan. 31-Feb. 4, 2027, in San Diego. The conference will bring together more than 2,000 participants from over 50 countries to focus on lysosomal and related rare disease research and treatment.

Why it matters: - WORLDSymposium is the largest international scientific meeting focused on lysosomal and related rare diseases. - The 2027 meeting will draw more than 2,000 researchers, clinicians, patient advocates, regulatory professionals and industry leaders from over 50 countries. - The conference is designed to help move lysosomal disease research from laboratory discovery toward human therapy.

What happened: - WORLDSymposium opened abstract submissions, award nominations, attendee registration and hotel reservations for the 23rd Annual WORLDSymposium. - The meeting is set for Jan. 31-Feb. 4, 2027, at the Manchester Grand Hyatt in San Diego, California. - General registration is open at worldsymposia.org.

The details: - Abstract submissions are open through Oct. 1, 2026, at 17:00 CDT. - Abstracts received by the deadline will be reviewed by the WORLDSymposium Scientific Committee for possible platform or poster presentation. - Notifications on primary abstract decisions will be issued by Nov. 2, 2026. - A Late-Breaking Abstract category will run Nov. 1-Dec. 1, 2026. - The late-breaking category is for investigators with new and impactful data that was not available by the primary deadline. - Award nominations are open through Sept. 1, 2026. - The 2027 awards include the Roscoe O. Brady Award, Patient Advocate Leader Award, New Treatment Award and Catalyst Award. - Attendees are encouraged to book early and reserve rooms in the official block at the Manchester Grand Hyatt. - Rooms are first come, first served and are expected to fill quickly.

Between the lines: - WORLDSymposium has grown since its 2004 founding from a narrower researchers' meeting into a cross-disciplinary forum that now includes regulatory strategy and industry development. - The meeting’s structure suggests an effort to keep pace with a fast-moving field where translational research and clinical development depend on close coordination. - The quoted leaders frame the conference as a rare venue for global collaboration, but those comments are promotional and not independently verified in the release.

What's next: - Abstract reviewers will begin evaluating submissions after the Oct. 1 deadline. - Late-breaking submissions will open in November for new data that emerges after the main deadline. - Award recipients and presentation selections should follow the committee review timeline later in 2026. - Participants will gather in San Diego for the annual scientific meeting in early 2027.

The bottom line: - WORLDSymposium is using its 2027 cycle to pull together research, advocacy and industry around rare disease development, with key deadlines now underway.